Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Epocal Announces FDA Clearance of Lactate Test
OTTAWA, Canada, June 15 /PRNewswire/ -- Epocal, Inc., a leading edge provider of point of care technology, announced today that... Read more
Tioga Pharmaceuticals Begins Phase 3 Trial of Asimadoline in Irritable Bowel Syndrome
San Diego, Calif. - June 3, 2010 - Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first... Read more